Dementia with Lewy bodies (DLB) may not be as well-known as other forms like Alzheimer’s, but is just as devastating, so the discovery that commonly used drugs may reduce the risk of the di
Researchers in the UK will soon start trialling blood tests that promise to diagnose dementia at clinics across the country in the hope of having them in rout
A partnership between Eisai and Lifenet that aims to improve insurance cover for people with early dementia has generated its first policy, part of an effort by the pharma
Researchers in the UK and China have used proteomics data from the UK Biobank to identify protein biomarkers in the blood that could give warning of dementia years before
Eisai has joined forces with Oita University in Japan to develop a machine-learning tool that may be able to predict whether someone is at risk of developing Alzheimer’s d
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
